COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 2264: Articles 22631-22640  | Next

Systematic examination of T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile
Law, J. C., Koh, W., Budylowski, P., Lin, J., Yue, F., Abe, K. T., Rathod, B., Girard, M., Li, Z., Rini, J. M., Mubareka, S., McGeer, A., Chan, A. K., Gingras, A.-C., Watts, T. H., Ostrowski, M.
10.1101/2020.08.27.20183319 — Posted: 2020-09-01 Discussion: Offsite
Microfluidic nano-scale qPCR enables ultra-sensitive detection of SARS-CoV-2
Xie, X., Gjorgjieva, T., Attieh, Z., Dieng, M. M., Arnoux, M., Khair, M., Moussa, Y., Al Jallaf, F., Rahiman, N., Jackson, C. A., Victoria, Z., Zafar, M., Ali, R., Piano, F., Gunsalus, K. C., Idaghdour, Y.
10.1101/2020.08.28.20183970 — Posted: 2020-09-01
Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness
Rubio-Rivas, M., Ronda, M., Padulles, A., Mitjavila, F., Riera-Mestre, A., Garcia-Forero, C., Iriarte, A., Mora, J. M., Padulles, N., Gonzalez, M., Solanich, X., Gasa, M., Suarez, G., Sabater, J., Perez-Fernandez, X. L., Santacana, E., Leiva, E., Ariza-Sole, A., Dallaglio, P. D., Quero, M., Soriano, A., Pasqualetto, A., Koo, M., Esteve, V., Antoli, A., Moreno, R., Yun, S., Cerda, P., Llaberia, M., Formiga, F., Fanlo, M., Montero, A., Chivite, D., Capdevila, O., Bolao, F., Pinto, X., Llop, J., Sabate, A., Guardiola, J., Cruzado, J. M., Comin-Colet, J., Santos, S., Jodar, R., Corbella, X.
10.1101/2020.08.31.20182428 — Posted: 2020-09-01
A common androgen synthesis variant is associated with COVID susceptibility
McManus, J. M., Sabharwal, N., Bazeley, P., Sharifi, N.
10.1101/2020.08.27.20183004 — Posted: 2020-09-01
Repeat testing for SARS-COV-2: Persistence of viral RNA is common, and clearance is slower in older age groups
Stehlik, P., Alcorn, K., Jones, A., Schlebusch, S., Wattiaux, A., Henry, D.
10.1101/2020.08.27.20183483 — Posted: 2020-09-01
Viral shedding dynamics reveals sputum as a reliable and cost-saving specimen for SARS-CoV-2 diagnosis within the first 10 days since symptom onset: A prospective cohort study
Levican-Asenjo, J. E., Almonacid, L. I., Valenzuela, G., Garcia, T., Rojas, L., Serrano, E., Pardo-Roa, C., Salinas, E., Avendano, M. J., Perazzo, F., Diaz, L. A., Valderrama, S., Ortega, M., Toro, A., Montecinos, V., Riquelme, A., Medina, R. A.
10.1101/2020.08.30.20183889 — Posted: 2020-09-01
Acute kidney injury is associated with severe and fatal outcomes in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
Parohan, M., Yaghoubi, S., Djalali, M., Seraji, A., Javanbakht, M. H., Mousavi, Z.
10.1101/2020.08.27.20183632 — Posted: 2020-09-01
Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh
Mahmud, A. S., Chowdhury, A., Uddin, R., Sojib, K. H., Chowdhury, S., Quader, M. T., Paul, S., Saidy, M. S., Engo-Monsen, K., Buckee, C. O.
10.1101/2020.08.28.20183905 — Posted: 2020-09-01
Unmasking the conversation on masks: Natural language processing for topical sentiment analysis of COVID-19 Twitter discourse
Sanders, A., White, R., Severson, L., Ma, R., McQueen, R., Alcanatara Paulo, H. C., Zhang, Y., Erickson, J. S., Bennett, K. P.
10.1101/2020.08.28.20183863 — Posted: 2020-09-01
DeepSOCIAL: Social Distancing Monitoring and Infection Risk Assessment in COVID-19 Pandemic
Rezaei, M., Azarmi, M.
10.1101/2020.08.27.20183277 — Posted: 2020-09-01 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).